San Diego, CA—(ENEWSPF)—August 10, 2018 By: Paul Armentano, NORML Deputy Director The use of cannabidiol products for the treatment of either a specific health condition or for general well-being is becoming prevalent among the general public, according to survey data published in the journal Cannabis and Cannabinoid Research. Researchers at[Read More…]
Health and Fitness
FDA Allows Marketing of First Direct-to-Consumer App for Contraceptive Use to Prevent Pregnancy
Silver Spring, Maryland—(ENEWSPF)—August 10, 2018 Contact: Deborah Kotz The U.S. Food and Drug Administration today permitted marketing of the first mobile medical application (app) that can be used as a method of contraception to prevent pregnancy. The app, called Natural Cycles, contains an algorithm that calculates the days of the[Read More…]
Clinicians Learning of Patient Overdose Deaths Reduce Future Prescriptions of Opioid Drugs
Bethesda, MD-(ENEWSPF)- The National Institutes of Health reported Thursday that patient overdose deaths had a direct impact on whether clinicians would prescribe opioid drugs in the future. An NIH-funded study shows clinicians reduced prescriptions following behavioral “nudge,” that they were more likely to reduce the number and dose of opioid[Read More…]
In Weary Post-Storm Puerto Rico, Medicaid Cutbacks Bode New Ills
San Juan, Puerto Rico—(ENEWSPF)—August 9, 2018 By: Sarah Varney and Carmen Heredia Rodriguez Blue tarps still dot rooftops, homes lack electricity needed to refrigerate medicines, and clinics chip away at debts incurred from running generators. Yet despite the residual effects from last year’s devastating hurricanes, Puerto Rico is moving ahead[Read More…]
Breathing ‘A Chore’: California Wildfires Threaten the Health of Young And Old
CALIFORNIA—(ENEWSPF)—August 9, 2018 By: Anna Gorman and Ana B. Ibarra Debbie Dobrosky noticed a peculiar hue in the sky on Monday — “a very ugly yellow casting” — as she peeked outside. A large cloud of smoke had begun to cover the sun. By Tuesday, the smoke was so heavy that[Read More…]
Nationwide Recall of CVS Health 12 Hour Sinus Relief Nasal Mist
Possible Microbiological Contamination Holly Hill, FL–(ENEWSPF)—August 9, 2018 Contact: Joan Sanger, Site Head of Quality, Product Quest Manufacturing Holly Hill, FL, Product Quest Manufacturing (“Product Quest”) is voluntarily recalling Lot# 173089J of CVS Health 12 Hour Sinus Relief Nasal Mist, a clear, colorless liquid, to the consumer level. THolly Hill,[Read More…]
How the US Drug War Fuels Migration, Violence and Trauma
Before blaming migrants for their plight, we must look at how the drug war creates violence and displacement CALIFORNIA—(ENEWSPF)—August 6, 2018 By: Eunisses Hernandez and Norma Palacios Last month, Marco Antonio Munoz, a 39-year-old Honduran asylum seeker died alone of suicide in his cell. The inescapable violence in Honduras — a substantial portion[Read More…]
Hostess Announces Voluntary Recall of Certain Cookies ‘n Creme Brownies
Kansas City, MO –(ENEWSPF)—August 6, 2018 By: Rosemary Piser The Food and Drug Administration (FDA) announced that Hostess Brands, LLC has become aware that the “Contains” statement on Hostess® Cookies ‘n Crème Brownies does not list “egg” as an allergen. No reports of injury or illness have been reported to[Read More…]
FDA Encourages Development of Novel Medicines for Treatment of Opioid Abuse
Silver Spring, Maryland—(ENEWSPF)—August 6, 2018 By: Michael Felberbaum The U.S. Food and Drug Administration today issued new scientific recommendations aimed at encouraging more widespread innovation and development of novel medication-assisted treatment (MAT) drugs for the treatment of opioid use disorder (OUD). New draft guidance issued today outlines new ways for[Read More…]
How Rival Opioid Makers Sought To Cash In On Alarm Over OxyContin’s Dangers
CALIFORNIA—(ENEWSPF)—August 6, 2018 By: Fred Schulte As Purdue Pharma faced mounting criticism over deaths linked to OxyContin, rival drugmakers saw a chance to boost sales by stepping up marketing of similarly dangerous painkillers, such as fentanyl, morphine and methadone, Purdue internal documents reveal. Purdue’s 1996-2002 marketing plans for OxyContin, which[Read More…]
